Initial Paclitaxel Improves Outcome Compared With CMFP Combination Chemotherapy as Front-Line Therapy in Untreated Metastatic Breast Cancer - Concepedia

Concepedia

Publication | Closed Access

Initial Paclitaxel Improves Outcome Compared With CMFP Combination Chemotherapy as Front-Line Therapy in Untreated Metastatic Breast Cancer

211

Citations

46

References

1999

Year

James F. Bishop, Joanna Dewar, Guy C. Toner, Jennifer Smith, Martin H.N. Tattersall, Ian Olver, Stephen P. Ackland, Ian Kennedy, David Goldstein, Howard Gurney,

Journal of Clinical Oncology

Abstract

Initial paclitaxel was associated with significantly less myelosuppression and fewer infections, with longer survival and similar quality of life and control of metastatic breast cancer compared with CMFP.

References

	Year	Citations

Page 1